Importantly, no mortality related to infections was observed in the four IL-10-DLI treated IR patients, whereas the IL-10-DLI patients who did not achieve immune reconstitution died for infections and relapse at a median of 72 days from haplo-HSCT. This evidence concerns the gene IL10 and infection.